Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma

Blood

Volumn 91, Issue 12, 1998, Pages 4457-4463

  Chesi, Marta ^b   Bergsagel, P Leif ^b   Shonukan, Oluwatoyin O ^b   Martelli, Maria Luisa ^b   Brents, Leslie A ^b   Chen, Theresa ^b   Schröck, Evelin ^b   Ried, Thomas ^b   Kuehl, W Michael ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LAMBDA CHAIN; TRANSCRIPTION FACTOR;

ARTICLE; CHROMOSOME 16Q; CHROMOSOME TRANSLOCATION 16; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; KARYOTYPE; MULTIPLE MYELOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTO ONCOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0031839633     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.12.4457     Document Type: Article

References (28)

1. Korsmeyer SJ: Chromosomal translocations in lymphoid malignancies reveal novel proto-oncogenes. Annu Rev Immunol 10:785, 1992
2. Nishida K, Tamura A, Nakazawa N, Ueda Y, Abe T, Matsuda F, Kashima K, Taniwaki M: The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization. Blood 90:526, 1997
3. Bergsagel PL, Chesi M, Nardini E, Brents LA, Kirby SL, Kuehl WM: Promiscuous trans location s into immunoglobulin heavy chain switch regions in multiple myeloma. Proc Natl Acad Sci USA 93:13931, 1996
4. Chesi M, Bergsagel PL, Brents LA, Smith CM, Gerhard DS, Kuehl WM: Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines. Blood 88:674, 1996
5. Chesi M, Nardini E, Brents LA, Schrock E, Ried T, Kuehl WM, Bergsagel PL: Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Nat Genet 16:260, 1997
6. Iida S, Rao PH, Butler M, Corradini P, Boccadoro M, Klein B, Chaganti RS, Dalla-Favera R: Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma. Nat Genet 17:226, 1997
7. Lai JL, Zandecki M, Mary JY, Bernardi F, Izydorczyk V, Flactif M, Morel P, Jouet JP, Bauters F, Facon T: Improved cytogenetics in multiple myeloma: A study of 151 patients including 117 patients at diagnosis. Blood 85:2490, 1995
8. Sawyer JR, Waldron JA, Jagannath S, Barlogie B: Cytogenetic findings in 200 patients with multiple myeloma. Cancer Genet Cytogenet 82:41, 1995
9. Taniwaki M, Nishida K, Takashima T, Nakagawa H, Fujii H, Tamaki T, Shimazaki C, Horiike S, Misawa S, Abe T, Kashima K: Nonrandom chromosomal rearrangements of 14q32.3 and 19p13.3 and preferential deletion of Ip in 21 patients with multiple myeloma and plasma cell leukemia. Blood 84:2283, 1994
10. Pegoraro L, Malavasi F, Bellone G, Massaia M, Boccadoro M, Saglio G, Guerrasio A, Benetton G, Lombardi L, Coda R, Avanzi GC: The human myeloma cell line LP-1: A versatile model in which to study early plasma-cell differentiation and c-myc activation. Blood 73:1020, 1989
11. Yoshida MC, Nishizawa M, Kataoka K. Goto N, Fujiwara KT, Kawai S: Localization of the human MAP protooncogene on chromosome 16 to bands q22-q23. Cytogenet Cell Genet 58:2003, 1991
12. Bergsagel PL, Brents LA, Trepel JB, Kuehl WM: Genes expressed selectively in murine and human plasma cell neoplasms. Curr Top Microbiol Immunol 194:57, 1995
13. Kurschner C, Morgan JI: The maf proto-oncogene stimulates transcription from multiple sites in a promoter that directs Purkinje neuron-specific gene expression. Mol Cell Biol 15:246, 1995
14. Bellamy WT, Dalton WS, Gleason MC, Grogan TM, Trent JM: Development and characterization of a melphalan-resistant human multiple myeloma cell line. Cancer Res 51:995, 1991
15. Avet-Loiseau H, Brigaudeau C, Talmant P, Laï JL, Daviet A, Praloran V, Rapp MJ, Harousseau JL, Facon T, Bataile R: High incidence of Ig heavy chain gene rearrangements with various partner chromosomes in multiple myeloma, as shown by molecular cytogenetics. Blood 90:89a, 1997 (abstr, suppl 1)
16. Vaandrager JW, Kluin P, Schuuring E: The t(11;14) (q13;q32) in multiple myeloma cell line KMS12 has its 11q13 breakpoint 330 kb centromeric from the cyclin D1 gene [letter; comment]. Blood 89:349, 1997
17. Vaandrager JW, Schuuring E, Zwikstra E, de Boer CJ, Kleiverda KK, van Krieken JH, Kluin-Nelemans HC, van Ommen GJ, Raap AK, Kluin PM: Direct visualization of dispersed 11q13 chromosomal translocations in mantle cell lymphoma by multicolor DNA fiber fluorescence in situ hybridization. Blood 88:1177, 1996
18. Taub R, Kelly K, Battey J, Latt S, Lenoir CM, Tantravahi U, Tu Z, Leder P; A novel alteration in the structure of an activated c-myc gene in a variant t(2;8) Burkitt lymphoma. Cell 37:511, 1984
19. Adachi M, Cossman J, Longo D, Croce CM, Tsujimoto Y: Variant translocation of the bcl-2 gene to immunoglobulin lambda light chain gene in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 86:2771, 1989
20. Komatsu H, Iida S, Yamamoto K, Mikuni C, Nitta M, Takahashi T, Ueda R, Seto M: A variant chromosome translocation at 11q13 identifying PRAD1/cyclin D1 as the BCL-1 gene. Blood 84:1226, 1994
21. Nishizawa M, Kataoka K, Goto N, Fujiwara KT, Kawai S: v-maf, a viral oncogene that encodes a "leucine zipper" motif. Proc Natl Acad Sci USA 86:7711, 1989
22. Kataoka K, Nishizawa M, Kawai S: Structure-function analysis of the maf oncogene product, a member of the b-Zip protein family. J Virol 67:2133, 1993
23. Klein B, Zhang X-G, Lu Z-Y, Bataille R: Inierleukin-6 in human multiple myeloma. Blood 85:863, 1995
24. Nacheva E, Fischer PE, Sherrington PD, Labastide W, Lawlor E, Conneaily E, Blaney C, Hayhoe FG, Karpas A: A new human plasma cell line, Karpas 620, with translocations involving chromosomes 1, 11 and 14. Br J Haematol 74:70, 1990
25. Rao PH, Cigudosa J, Ning Y, Calasanz MJ, Tagawa S, Michaela S, Klein B, Dalla-Favera R, Ried T, Chaganti RSK: Karyotypic complexity of multiple myeloma defined by multicolor spectral karyotyping. Blood 90:87a, 1997 (abstr, suppl 1)
26. Zhang XG, Gaillard JP, Robillard N, Lu ZY, Gu ZJ, Jourdan M, Boiron JM, Bataille R, Klein B: Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma. Blood 83:3654, 1994
27. Han S, Dillon SR, Zheng B, Shimoda M, Schlissel MS, Kelsoe G: V(D)J recombinase activity in a subset of germinal center B lymphocytes [see comments]. Science 278:301, 1997
28. Dib C, Faure S, Fizames C, Samson D, Drouot N, Vignal A, Millasseau P, Marc S, Hazan J, Seboun E, Lathrop M, Gyapay G, Morissette J, Weissenbach J: A comprehensive genetic map of the human genome based on 5,264 microsatellites [see comments]. Nature 380:152, 1996